Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL

NCT05497310 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Promyelocytic Leukemia

Interventions

DRUG: Arsenic trioxide
DRUG: all-trans retinoic acid

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez